“DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUSType 2 diabetes mellitus is a common chronic disease that causes significant morbidity and mortality worldwide. Diabetes results from a combination of increased hepatic glucose product” (2024) International Research Journal of Pharmacy, 2(1), pp. 32–40. Available at: https://irjponline.org/index.php/irjp/article/view/1741 (Accessed: 25 August 2026).